drugset / Trial / NCT00170976

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

NCT00170976

Phase 3 Completed 403 enrolled Novartis
RandomizedSingle-groupOpen-labelTreatment

Summary

A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2307.

Timeline

Start
2004-04
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Valsartan Small molecule 320 mg

Indications